Dr. Bimal Shah Joins Livongo to Lead Hypertension Product

MOUNTAIN VIEW, Calif., Sept. 21, 2017

"Dr. Bimal Shah brings extensive heart disease knowledge to Livongo," said Dr. Jennifer Schneider, Chief Medical Officer of Livongo Health. "His clinical experience coupled with his experience building data-driven healthcare products will play a critical role in Livongo's expansion to hypertension and beyond."

As Senior Vice President for Clinical and Strategic Partnerships, Dr. Shah will provide clinical guidance on Livongo's hypertension product. Shah will also advance Livongo's key ecosystem relationships.

Previously, Dr. Shah was the Chief Officer for Emerging Technology and Informatics at Premier Inc., (NASDAQ: PINC). Prior to Premier, Dr. Shah served as an Assistant Professor in both the Department of Medicine and Fuqua School of Business at Duke University. Dr. Shah remains on faculty at Duke as a practicing cardiologist and serves as a member of both the Board of Advisors for the Duke School of Nursing and Board of Visitors for the University of North Carolina at Chapel Hill.  Dr. Shah graduated from the University of North Carolina at Chapel Hill with a Bachelor of Arts in Economics and Chemistry, with highest honors, and earned both an MD and MBA from Duke University. Dr. Shah completed his residency in Internal Medicine at Stanford University before finishing a general cardiology fellowship at Duke University.

"I am very excited to pair my medical experiences with the programs that Livongo has developed to empower people to better manage multiple chronic conditions," said Dr. Shah. "Livongo's expansion to hypertension is revolutionary in the healthcare industry and I truly look forward to driving the progress ahead."

Livongo's digital platform for diabetes management has been implemented by over 200 leading Fortune 500 companies, innovative health systems, and the largest health plans and pharmacy benefit managers, with more than 50,000 people with diabetes enrolled today.